
Who We Are?
Cesa Alliance is an International collaboration of Universities, Laboratories, Independent Doctors and researchers.
CLINICAL TRIAL EFFICACY
Examples
Herpes Simplex : 3 topical applications stops cold sores within 6 hours
Papilloma Virus : 3 x 2 applications results in warts disappearance in 3 weeks
COVID-19 : 5 Sublingual tablets stops stops viral replication within 2 hours
Hepatitis B/C : 4 week treatment sublingual tablets clears the virus from the body
HPV Cervical : One topical application on Cervix – stops viral replication and starts lesion clearance.
Other
Deactivation of over 300 virus types have been patented of which 24 have been studied and are ready for further Clinical Trials
Rather than looking for solutions in traditional closed and highly structured and controlled private organizations, Cesa’s collaborators roam around the world looking for ideas and answers, highly advanced techniques sometimes based on ancient old wisdom. We are an Alliance in the broadest sense, giving us unlimited access to knowledge and experience.
Cesa Alliance is an International collaboration of Universities, Laboratories, Independent Doctors and researchers.
Cesa Alliance Discovers, Develops and Synthesizes OMNI spectrum anti- infectives and anti-inflammatories. We organize Safety studies and Observational efficacy studies in order to apply for worldwide patents. Further we organize Placebo Controlled Clinic Trials and prepare the documentation for our medical solutions to be presented to FDA and EMEA for registration.
We have created 3 OMNI spectrum anti- infectives. OMNIBACTERIOL an OMNI spectrum anti-bacterial, OMNIVIROL an OMNI spectrum Anti-viral and OMNIPARACITOL an OMNI spectrum Anti-parasite. Further we developed a molecule RELUMINOL for the treatment of Alzheimer’s disease. Over 250 worldwide patents have been granted and hundreds more are in the pipe line.